FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 138 filers reported holding FLEXION THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $146,000 | +9.8% | 11,750 | 0.0% | 0.06% | -1.5% |
Q4 2018 | $133,000 | -55.5% | 11,750 | -26.6% | 0.07% | -43.1% |
Q3 2018 | $299,000 | -22.7% | 16,000 | +6.7% | 0.12% | -20.5% |
Q2 2018 | $387,000 | +15.2% | 15,000 | 0.0% | 0.15% | +10.6% |
Q1 2018 | $336,000 | – | 15,000 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Clearline Capital LP | 391,076 | $7,317,000 | 4.33% |
Rubric Capital Management LP | 2,125,000 | $39,759,000 | 4.20% |
Gagnon Advisors, LLC | 225,062 | $4,211,000 | 2.52% |
GAGNON SECURITIES LLC | 450,655 | $8,432,000 | 1.94% |
MILLER VALUE PARTNERS, LLC | 2,881,200 | $53,907,000 | 1.74% |
PECONIC PARTNERS LLC | 222,965 | $4,172,000 | 1.05% |
ARDSLEY ADVISORY PARTNERS LP | 415,000 | $7,765,000 | 1.05% |
Rhenman & Partners Asset Management AB | 532,812 | $9,969,000 | 1.00% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 574,483 | $10,749,000 | 0.75% |
Kerrisdale Advisers, LLC | 37,145 | $695,000 | 0.68% |